Kropz PLC

Extension of Open Offer Closing Date

RNS Number : 7343P
Kropz PLC
12 June 2020
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

12 June 2020

Kropz Plc

("Kropz" or the "Company")

 

Extension of Open Offer Closing Date

 

Further to the Company's announcement of 1 June 2020, Kropz Plc (AIM: KRPZ), an emerging African phosphate explorer and developer, announces that it will extend the latest time and date for receipt of completed Application Forms and payment in full under the Open Offer or settlement of the relevant CREST instructions (as appropriate) from 11.00 a.m. on 15 June 2020 to 11.00 a.m. on 19 June 2020.

 

The Company decided to extend the Open Offer due to the administration delays which were experienced whilst satisfying all of the conditions precedent for the Equity Facility, as announced on 10 June 2020.

 

The revised timetable of principal events is detailed below. The change in timetable does not impact applications already made, which continue to have effect and remain binding. Existing Application Forms can be used in accordance with the revised timetable set out below.

 

Capitalised terms in this announcement are as defined in the circular posted to shareholders on 1 June 2020.

 

Revised Expected Timetable of Principal Events

 

Latest time and date for receipt of completed Application Forms and payment in full under the Open Offer or settlement of relevant
CREST instruction (as appropriate)

 

11 a.m. on 19 June 2020

Announcement of result of the Open Offer

 

23 June 2020

Open Offer Admission and commencement of dealings in the Open Offer Shares on AIM

 

8 a.m. on 25 June 2020

Open Offer Shares credited to CREST members' accounts

 

25 June 2020

Despatch of definitive share certificates in certificated form

within 5 business days of the Open Offer Admission

 

(i)  References to times in the Open Offer Circular are to London time (unless otherwise stated).

(ii)  If any of the details contained in the timetable above should change, the revised times and dates will be notified by means of an announcement through a Regulatory Information Service.

 

 

For further information visit www.kropz.com or contact:

Kropz Plc

 

Mark Summers (Interim CEO)

+27 (0)79 744 8708

 

 

Grant Thornton UK LLP ("GT")

Nominated Adviser

Richard Tonthat

Samantha Harrison

Niall McDonald

+44 (0)20 7383 5100

 

 

Hannam & Partners ("H&P")

Joint Broker

Andrew Chubb

Ernest Bell

 +44 (0)20 7907 8500

 

Mirabaud Securities Ltd ("Mirabaud")

Joint Broker

Rory Scott

Edward Haig-Thomas

+44 (0)20 3167 7220

+44 (0)20 3167 7222

 

 

Tavistock

Financial PR & IR (UK)

Emily Moss

Jos Simson

Oliver Lamb

+44 (0)20 7920 3150

[email protected]

 

R&A Strategic Communications

PR (South Africa)

James Duncan

+27 (0)11 880 3924

[email protected] 

About Kropz

Kropz is an emerging African phosphate explorer and developer, with an advanced stage phosphate project in South Africa and a phosphate project in the Republic of Congo. The vision of the Group is to become a leading independent phosphate rock producer and to develop into an integrated, mine-to-market plant nutrient company focusing on sub-Saharan Africa.

ENDS


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCQFLFFBQLXBBE